https://biocidin.wistia.com/medias/wxusy0cfns Go here for presentation (Approx 22 Min)
Part 1: Clinical Considerations of Clostridia Bacterial Concerns – Pathogenicity Mechanisms
Biocidin Education Series
For more:
- https://www.merckmanuals.com/professional/infectious-diseases/anaerobic-bacteria/overview-of-clostridial-infections
- https://madisonarealymesupportgroup.com/2019/03/29/cochrane-review-probiotics-reduce-c-diff-by-70-in-high-risk-patients-taking-antibiotics/
- https://madisonarealymesupportgroup.com/2018/09/15/prebiotics-probiotics-do-they-really-work-for-gut-health/
- https://madisonarealymesupportgroup.com/2020/09/15/probiotics-vs-prebiotics-the-differences-why-you-need-both/
- https://madisonarealymesupportgroup.com/2021/05/11/candida-lyme/
- https://www.contagionlive.com/view/increased-prevalence-of-candida-and-c-diff-coinfection-requires-more-awareness
- https://academic.oup.com/cid/article/59/11/1648/413697
